Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib + Paclitaxel in Advanced Angiosarcoma
NCT02212015Phase 2Terminated
- Sponsor
- Heidelberg University
- Start
- Jul 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pazopanib in angiosarcoma, sponsored by Heidelberg University. Started Jul 2014; status: terminated.
02
Drugs
pazopanib
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT02212015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212015.